Inventiva (IVA) Prepaid Assets (2018 - 2025)
Inventiva (IVA) recorded quarterly Prepaid Assets of $4.7 million in Q4 2025, down 99.99% quarter-over-quarter from $43.9 billion in Q2 2025, and up 78.43% on a YoY basis from $2.6 million in Q4 2024.
Inventiva (IVA) Prepaid Assets (2018 - 2025) Analysis & Trends
Inventiva's Prepaid Assets history runs 8 years deep, the most recent figure standing at $4.7 million for Q4 2025.
- In Q4 2025, Prepaid Assets rose 78.43% year-over-year to $4.7 million; the TTM figure through Dec 2025 stood at $4.7 million (up 78.43% YoY), while the FY2025 annual figure was $4.7 million, up 78.43% from the prior year.
- Prepaid Assets was $4.7 million for Q4 2025 at Inventiva, down from $43.9 billion in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $43.9 billion in Q2 2025 to a low of $2.6 million in Q4 2024.
- Historically, Prepaid Assets has averaged $5.9 billion across 5 years, with a median of $8.8 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets plunged 99.96% in 2023, then jumped 579423.29% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $8.5 million in 2021, then increased by 2.91% to $8.8 million in 2022, then plunged by 42.91% to $5.0 million in 2023, then slumped by 47.91% to $2.6 million in 2024, then soared by 78.43% to $4.7 million in 2025.
- The last three Prepaid Assets figures came in at $4.7 million (Q4 2025), $43.9 billion (Q2 2025), and $2.6 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.66 Mn |
| Jun 30, 2025 | 43.93 Bn |
| Dec 31, 2024 | 2.61 Mn |
| Jun 30, 2024 | 7.58 Mn |
| Dec 31, 2023 | 5.01 Mn |
| Jun 30, 2023 | 9.34 Mn |
| Dec 31, 2022 | 8.78 Mn |
| Jun 30, 2022 | 21.00 Bn |
| Dec 31, 2021 | 8.53 Mn |
| Jun 30, 2021 | 15.46 Mn |
| Mar 31, 2021 | 9.84 Mn |
| Dec 31, 2020 | 3.95 Mn |
| Jun 30, 2020 | 5.04 Mn |
| Dec 31, 2019 | 547,909.40 |
| Dec 31, 2018 | 1.35 Mn |